<DOC>
	<DOC>NCT02953132</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and tolerability of ascending single and multiple oral doses of MT-4129 in healthy subjects.</brief_summary>
	<brief_title>A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy and free from clinically significant illness or disease Male or female subjects aged 18 to 55 years or elderly male subjects aged ≥65 A body weight of ≥60 kg for males and ≥50 kg for females, and a body mass index ranging from 18 to 30 kg/m2 Participated in more than three clinical studies involving administration of an IMP in the previous year, or any study within 12 weeks Clinically significant endocrine, thyroid, hepatic, respiratory, gastro intestinal, neurological, renal, cardiovascular disease, or history of any significant psychiatric/psychotic illness disorder Clinically relevant abnormal medical history, physical findings or laboratory values</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>